BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32347094)

  • 21. Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy.
    Jacob K S; Ganguly S; Kumar P; Poddar R; Kumar A
    J Biomol Struct Dyn; 2017 May; 35(7):1446-1463. PubMed ID: 27142238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of 1,2,3-selenadiazole analogues as antifungal agents using a scaffold hopping approach.
    Xu H; Cao C; Wang X; Guo MB; Yan ZZ; An R; Zhang R; Dong EH; Mou YH; Hou Z; Guo C
    Bioorg Chem; 2021 Oct; 115():105182. PubMed ID: 34333426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-Delta7-24, 25-dihydrolanosterol.
    Hargrove TY; Wawrzak Z; Liu J; Waterman MR; Nes WD; Lepesheva GI
    J Lipid Res; 2012 Feb; 53(2):311-20. PubMed ID: 22135275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infections.
    Xu H; Yan ZZ; Guo MB; An R; Wang X; Zhang R; Mou YH; Hou Z; Guo C
    Eur J Med Chem; 2021 Apr; 216():113337. PubMed ID: 33713977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.
    Flowers SA; Colón B; Whaley SG; Schuler MA; Rogers PD
    Antimicrob Agents Chemother; 2015 Jan; 59(1):450-60. PubMed ID: 25385095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents.
    Thamban Chandrika N; Shrestha SK; Ngo HX; Tsodikov OV; Howard KC; Garneau-Tsodikova S
    J Med Chem; 2018 Jan; 61(1):158-173. PubMed ID: 29256601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular basis of resistance to azole antifungals.
    Lupetti A; Danesi R; Campa M; Del Tacca M; Kelly S
    Trends Mol Med; 2002 Feb; 8(2):76-81. PubMed ID: 11815273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and optimization of highly-selective fungal CYP51 inhibitors.
    Hoekstra WJ; Garvey EP; Moore WR; Rafferty SW; Yates CM; Schotzinger RJ
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3455-8. PubMed ID: 24948565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the sterol 14α-demethylases of Fusarium graminearum identifies a novel genus-specific CYP51 function.
    Fan J; Urban M; Parker JE; Brewer HC; Kelly SL; Hammond-Kosack KE; Fraaije BA; Liu X; Cools HJ
    New Phytol; 2013 May; 198(3):821-835. PubMed ID: 23442154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery.
    Keniya MV; Sabherwal M; Wilson RK; Woods MA; Sagatova AA; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
    Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sterol content analysis suggests altered eburicol 14alpha-demethylase (CYP51) activity in isolates of Mycosphaerella graminicola adapted to azole fungicides.
    Bean TP; Cools HJ; Lucas JA; Hawkins ND; Ward JL; Shaw MW; Fraaije BA
    FEMS Microbiol Lett; 2009 Jun; 296(2):266-73. PubMed ID: 19459949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of sterol biosynthesis and validation of 14α-demethylase as a drug target in Acanthamoeba.
    Thomson S; Rice CA; Zhang T; Edrada-Ebel R; Henriquez FL; Roberts CW
    Sci Rep; 2017 Aug; 7(1):8247. PubMed ID: 28811501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans.
    Binjubair FA; Parker JE; Warrilow AG; Puri K; Braidley PJ; Tatar E; Kelly SL; Kelly DE; Simons C
    ChemMedChem; 2020 Jul; 15(14):1294-1309. PubMed ID: 32459374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
    Monk BC; Keniya MV; Sabherwal M; Wilson RK; Graham DO; Hassan HF; Chen D; Tyndall JDA
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
    Emami S; Tavangar P; Keighobadi M
    Eur J Med Chem; 2017 Jul; 135():241-259. PubMed ID: 28456033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
    Zhao S; Wei P; Wu M; Zhang X; Zhao L; Jiang X; Hao C; Su X; Zhao D; Cheng M
    Bioorg Med Chem; 2018 Jul; 26(12):3242-3253. PubMed ID: 29748145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds.
    Kudo M; Ohi M; Aoyama Y; Nitahara Y; Chung SK; Yoshida Y
    J Biochem; 2005 May; 137(5):625-32. PubMed ID: 15944416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyridylethanol(phenylethyl)amines are non-azole, highly selective Candida albicans sterol 14α-demethylase inhibitors.
    Ogris I; Zelenko U; Sosič I; Gobec M; Skubic C; Ivanov M; Soković M; Kocjan D; Rozman D; Golič Grdadolnik S
    Bioorg Chem; 2021 Jan; 106():104472. PubMed ID: 33261849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-lactam substituted polycyclic fused pyrrolidine/pyrrolizidine derivatives eradicate C. albicans in an ex vivo human dentinal tubule model by inhibiting sterol 14-α demethylase and cAMP pathway.
    Gowri M; Sofi Beaula W; Biswal J; Dhamodharan P; Saiharish R; Rohan prasad S; Pitani R; Kandaswamy D; Raghunathan R; Jeyakanthan J; Rayala SK; Venkatraman G
    Biochim Biophys Acta; 2016 Apr; 1860(4):636-47. PubMed ID: 26723175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.